Show all News

We are working to develop our technology and commercialise MSC-based pharmaceuticals – find out more about our day-to-day work.

We’ve begun the process of accelerating thanks to MIT Enterprise Forum Poland

We are one of 18 innovative companies taking part in the 5th edition of MIT Enterprise Forum Poland accelerator program. There are three months of hard work and immense, new challenges ahead. If we are lucky enough to be among those who are selected to move on, our next stop is Boston Massachusetts,, USA, where we will take part in a special Bootcamp. Oh! Did we forget to mention that there’s also 100k PLN up for grabs in the CVC Young Innovator Awards contest? During the accelerator program we’ll be taught some plain English: learning how to present an innovative tech solution in a way that customers, partners and investors around the world are able to understand. There will also be a chance to take our innovative business idea out on a trial run, testing it using the expert opinions and technical resources provided by program partners.

Wrote about us

Bioceltix is ​​working on drugs based on stem cells for animals [interview]

MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing stem-cell-based biopharmaceuticals.  These biopharmaceuticals are a safer as well as more effective alternative to synthetic drugs, which treat only symptoms, not ...


Innowacje na start: Chivas Venture and Bioceltix

We hope you had a chance to tune in to „Radio dla Ciebie” during the „Let’s start with Innovation” („Innowacje na start”) show – that’s for coverage of Chivas Ventures. The forth edition of this contest for startups that are socially involved has now come, gone and guess what? The jury ...


Another round of the prestigious contest designed for social-involved startups – Chivas Venture–  is behind us. We are among the five companies that, on January 17th 2019, will take part in the grand finale of the contest – which is happening in Warsaw. That mid-January ...


Łukasz Bzdzion talks biopharmaceuticals for animals on Polish Radio

The CEO of Bioceltix, Łukasz Bzdion, during an interview for Channel 4 of Polish Radio, answered question regarding the possibility of treating animals using stem-cell-baed biopharmaceuticals and more. The interview starts in the 37th minute.   


(Un)limited stem cells Poland is among the countries where innovative biopharmaceuticals re being designed to treat household animals. Bioceltix is developing MSC-based medicines for dogs, horses and cats. The biopharmaceuticals, which are made in Poland, utilise the anti-inflammatory and ...